Altimmune, Inc. Quarterly Weighted Average Number of Shares Outstanding, Diluted from Q1 2014 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Altimmune, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q1 2014 to Q3 2024.
  • Altimmune, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2024 was 71.1M shares, a 32.5% increase year-over-year.
  • Altimmune, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 53.2M shares, a 13.5% increase from 2022.
  • Altimmune, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 46.9M shares, a 13.7% increase from 2021.
  • Altimmune, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 41.3M shares, a 61% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 71.1M +17.5M +32.5% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 70.9M +20.2M +39.9% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 70.8M +20.7M +41.2% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 53.2M +6.32M +13.5% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-27
Q3 2023 53.6M +4.35M +8.82% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 50.7M +3.19M +6.71% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 50.1M +6.16M +14% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 46.9M +5.64M +13.7% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-27
Q3 2022 49.3M +7.92M +19.1% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 47.5M +6.15M +14.9% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 44M +5.05M +13% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 41.3M Oct 1, 2021 Dec 31, 2021 10-K 2023-02-28
Q3 2021 41.4M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 41.4M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 38.9M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2016 65.7M +1.67M +2.61% Oct 1, 2016 Dec 31, 2016 10-K 2017-03-14
Q3 2016 65.8M +1.63M +2.54% Jul 1, 2016 Sep 30, 2016 10-Q 2016-11-04
Q2 2016 65.2M +1.46M +2.29% Apr 1, 2016 Jun 30, 2016 10-Q 2016-08-04
Q1 2016 64.4M +425K +0.66% Jan 1, 2016 Mar 31, 2016 10-Q 2016-05-09
Q4 2015 64M Oct 1, 2015 Dec 31, 2015 10-K 2017-03-14
Q3 2015 64.2M Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-04
Q2 2015 63.7M Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-04
Q1 2015 64M +10.9M +20.6% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
Q1 2014 53M Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.